A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in ICU

NCT ID: NCT07249619

Last Updated: 2025-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-02

Study Completion Date

2028-01-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As part of this study, an intervention program aimed at preventing delirium in patients with subarachnoid hemorrhage treated in the intensive care unit will be implemented. Routine medical treatments, environmental adjustments, and a video-based communication program will be implemented to prevent delirium. In addition, basic body awareness training will be administered.

Patients will be divided into two groups. One group will receive only the routine treatment program recommended by international guidelines (medical, enviromental adjustment and face-to-face interview etc.), while the other group will receive body awareness therapy addition to routine interventions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subarachnoid Haemorrhagic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine Treatment

A treatment program will be implemented in line with the recommendations of international guidelines for the treatment of delirium.

Group Type ACTIVE_COMPARATOR

Routine Therapy (Medical, environmental accodamation, face-to-face commucation)

Intervention Type OTHER

In the treatment of delirium, a treatment program will be implemented in line with the recommendations of international guidelines.

ICU.Delibma

In addition to the treatment program implemented in line with the recommendations of international guidelines for the treatment of delirium, "Basic Body Awareness Therapy" and "Communication Program" will be applied.

Group Type EXPERIMENTAL

Routine Therapy (Medical, environmental accodamation, face-to-face commucation)

Intervention Type OTHER

In the treatment of delirium, a treatment program will be implemented in line with the recommendations of international guidelines.

Biopsychosocial-Based Multimodal Approach

Intervention Type PROCEDURE

Delirium treatment will be implemented in accordance with international guidelines. Additionally, a basic body awareness therapy and communication program will be implemented.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Routine Therapy (Medical, environmental accodamation, face-to-face commucation)

In the treatment of delirium, a treatment program will be implemented in line with the recommendations of international guidelines.

Intervention Type OTHER

Biopsychosocial-Based Multimodal Approach

Delirium treatment will be implemented in accordance with international guidelines. Additionally, a basic body awareness therapy and communication program will be implemented.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18-85,
* Patients scheduled for intensive care for at least 15 days due to SAH, unruptured intracranial aneurysm, and/or Arterovenous Malformation,
* Those with a Mini Mental State Examination score of \> 24,
* Those with a Glasgow Coma Score of 15,
* Those with motor function in at least one extremity,
* Those with pain \< 5/10 (according to the NRS)

Exclusion Criteria

* Patients whose GCS fell to 14 or below for any reason during the study period;
* Patients who developed septic shock and MODS;
* Patients requiring endotrachial intubation and mechanical ventilation due to ARDS;
* Those requiring vasopressors such as NE at a rate of \>0.25 mcg/kg/min;
* Terminal cancer cases;
* Patients with advanced chronic heart and lung failure and COPD;
* Those with a METS (exercise capacity) of \<4;
* Those with a history of dementia, Alzheimer's disease, or psychiatric illness;
* Those with vision, hearing, or speech problems that would interfere with communication;
* Those with a history of epilepsy;
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emre Şenocak

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emre Şenocak

Assoc. Prof. Dr.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hülya Ulusoy, PhD

Role: PRINCIPAL_INVESTIGATOR

Karadeniz Technical University

Nurel Ertürk, PhD

Role: PRINCIPAL_INVESTIGATOR

Tarsus University

Gizem Ergün, Physiotherapist

Role: PRINCIPAL_INVESTIGATOR

Karadeniz Technical University

Neslihan Hatınoğlu, PhD

Role: PRINCIPAL_INVESTIGATOR

Karadeniz Technical University

Müge Koşucu, PhD

Role: PRINCIPAL_INVESTIGATOR

Karadeniz Technical University

Duygu Yıldırım, Phyiotherapist

Role: PRINCIPAL_INVESTIGATOR

Trabzon Kanuni Training and Research Hospital

Arzu Erden Güner, PhD

Role: STUDY_CHAIR

Karadeniz Technical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Karadeniz Technical University, Farabi Hospital

Trabzon, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arzu Erden Güner, PhD

Role: CONTACT

+90 506 248 26 80

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Arzu Erden Güner, PhD

Role: primary

+90 506 248 26 80

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/6

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PupillOmetry for Prediction of DelirIUM
NCT05248035 ACTIVE_NOT_RECRUITING